Credit Suisse’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$3.15M Sell
107,703
-572,355
-84% -$17.4M ﹤0.01% 1574
2023
Q4
$25.6M Sell
680,058
-378,233
-36% -$13.9M 0.02% 592
2023
Q3
$47.7M Sell
1,058,291
-2,288
-0.2% -$139K 0.05% 391
2023
Q2
$78.1M Sell
1,060,579
-192,110
-15% -$13M 0.08% 263
2023
Q1
$73.5M Sell
1,252,689
-31,663
-2% -$1.75M 0.07% 269
2022
Q4
$64.8M Buy
1,284,352
+2,188
+0.2% +$131K 0.07% 305
2022
Q3
$112M Buy
1,282,164
+72,542
+6% +$7.62M 0.12% 167
2022
Q2
$138M Buy
1,209,622
+106,749
+10% +$12.3M 0.14% 144
2022
Q1
$143M Buy
1,102,873
+366,835
+50% +$52.9M 0.12% 168
2021
Q4
$133M Sell
736,038
-2,159
-0.3% -$374K 0.07% 285
2021
Q3
$110M Sell
738,197
-175,225
-19% -$26.8M 0.06% 337
2021
Q2
$138M Sell
913,422
-214,791
-19% -$29.9M 0.07% 280
2021
Q1
$147M Sell
1,128,213
-226,904
-17% -$29.1M 0.08% 285
2020
Q4
$163M Sell
1,355,117
-350,178
-21% -$34.3M 0.08% 265
2020
Q3
$127M Buy
1,705,295
+46,938
+3% +$3.25M 0.08% 281
2020
Q2
$117M Buy
1,658,357
+214,675
+15% +$14.7M 0.08% 239
2020
Q1
$94.7M Sell
1,443,682
-26,498
-2% -$2.11M 0.08% 235
2019
Q4
$120M Buy
1,470,180
+99,580
+7% +$7.64M 0.09% 230
2019
Q3
$99.1M Buy
1,370,600
+625,120
+84% +$45.9M 0.08% 224
2019
Q2
$64.1M Buy
745,480
+267,324
+56% +$21.7M 0.06% 349
2019
Q1
$38.7M Buy
478,156
+99,318
+26% +$7.43M 0.04% 521
2018
Q4
$23.2M Buy
378,838
+69,342
+22% +$4.69M 0.02% 718
2018
Q3
$22.3M Buy
309,496
+278,331
+893% +$17.5M 0.02% 812
2018
Q2
$1.64M Sell
31,165
-4,738
-13% -$223K ﹤0.01% 2635
2018
Q1
$1.56M Buy
35,903
+1,221
+4% +$56.1K ﹤0.01% 2620
2017
Q4
$1.68M Sell
34,682
-7,275
-17% -$367K ﹤0.01% 2573
2017
Q3
$2.14M Buy
41,957
+23,908
+132% +$1.15M ﹤0.01% 2493
2017
Q2
$778K Sell
18,049
-12,261
-40% -$509K ﹤0.01% 2856
2017
Q1
$1.23M Sell
30,310
-10,713
-26% -$395K ﹤0.01% 2705
2016
Q4
$1.39M Buy
41,023
+12,261
+43% +$422K ﹤0.01% 2741
2016
Q3
$1.1M Sell
28,762
-4,877
-14% -$182K ﹤0.01% 2873
2016
Q2
$1.15M Buy
33,639
+9,391
+39% +$293K ﹤0.01% 2802
2016
Q1
$676K Sell
24,248
-39,343
-62% -$1.08M ﹤0.01% 3015
2015
Q4
$1.98M Sell
63,591
-8,901
-12% -$263K ﹤0.01% 2288
2015
Q3
$2.25M Buy
72,492
+1,117
+2% +$40K ﹤0.01% 2169
2015
Q2
$2.69M Buy
71,375
+47,770
+202% +$1.74M ﹤0.01% 2305
2015
Q1
$829K Buy
23,605
+5,912
+33% +$195K ﹤0.01% 3149
2014
Q4
$587K Sell
17,693
-56,872
-76% -$1.76M ﹤0.01% 3581
2014
Q3
$2.04M Buy
74,565
+30,117
+68% +$825K ﹤0.01% 2473
2014
Q2
$1.28M Buy
44,448
+18,320
+70% +$494K ﹤0.01% 3073
2014
Q1
$749K Sell
26,128
-11,007
-30% -$301K ﹤0.01% 3376
2013
Q4
$948K Sell
37,135
-7,774
-17% -$186K ﹤0.01% 3326
2013
Q3
$1.06M Buy
44,909
+34,892
+348% +$778K ﹤0.01% 2902
2013
Q2
$206K Buy
+10,017
New +$185K ﹤0.01% 3842

Other funds holding OMCL

Credit Suisse's OMCL Position: Q1 2024 in Review

Credit Suisse reduced its Omnicell (OMCL) stake by 84% in Q1 2024, selling an estimated $17.4M and leaving 107,703 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1574.

Credit Suisse first reported a position in OMCL in Q2 2013 and has held it in 44 quarters since. The position peaked at $163M in Q4 2020. 266 funds tracked by Wall St. Rank hold OMCL as of Q1 2024.

  • Credit Suisse held 107,703 shares of Omnicell worth $3.15M as of Q1 2024.
  • Credit Suisse sold 572,355 Omnicell shares in Q1 2024, an estimated $17.4M.
  • Omnicell made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1574 holding.
  • Credit Suisse first reported a position in Omnicell in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Omnicell position peaked at $163M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held Omnicell as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.